Comera Life Sciences Holdings

CMRA · OTC

$0.0001−$0.0001 (−50.00%)TodayMarket closed · Oct 6, 9:54 AM ET

No price history for this range.

About CMRA

Comera Life Sciences Holdings, Inc. engages in developing medicines. The company is headquartered in Woburn, Massachusetts and currently employs 12 full-time employees. The company went IPO on 2020-12-15. The firm applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The firm is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. The company also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.

Employees: 12
Headquarters: Woburn, Massachusetts
Listed: Dec 15, 2020
Sector: Health Care
Industry: Biotechnology
Website: comeralifesciences.com

Leadership

Comera Life Sciences Holdings executives
Name	Title	Since	Age
Jeffrey Hackman	—	2021	61
Michael Campbell	—	—	55
Robert Mahoney	—	—	59
Janice Mccourt	—	—	61
Roopom Banerjee	—	—	46
Kirsten Flowers	—	—	48
Stuart Randle	—	—	63
Rev. Dr. James Sherblom	—	—	67
Edward Sullivan	—	—	60

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.